• Explore /
  • Poster
  • / LENVAGIST - A multicenter, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib and sunitinib.

LENVAGIST - A multicenter, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib and sunitinib.

Abstract Poster

Authors

null

Axel Le Cesne

Institut Gustave Roussy, Villejuif, France

Axel Le Cesne , Claire Cropet , Julien Gautier , Stéphanie Gagne , Katia Francourt , Emilie Remir , Caroline Hernandez , Armelle Dufresne , Isabelle Laure Ray-Coquard , Mélodie Carbonnaux , Benoite Mery , Helene Vanacker , Francois Bertucci , Simon Launay , Delphine Louvel-Perrot , Audrey Monneur , Mehdi Brahmi , Jean-Yves Blay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Gastrointestinal Stromal Tumors (GIST)

Clinical Trial Registration Number

NCT04193553

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS11568)

DOI

10.1200/JCO.2020.38.15_suppl.TPS11568

Abstract #

TPS11568

Poster Bd #

456

Abstract Disclosures

Similar Posters

First Author: M. Ryu

First Author: Suzanne George

First Author: Yemarshet Kelemework Gebreyohannes

First Author: Steven Bialick